Clinical Trials Directory

Trials / Completed

CompletedNCT05586620

3 Snip Punctoplasty With and Without Mitomycine C.

Comparative Study on 3 Snip Punctoplasty With and Without Mitomycine C in the Management of Punctual Stenosis or Occlusion

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
18 (actual)
Sponsor
Al-Azhar University · Academic / Other
Sex
All
Age
16 Years – 63 Years
Healthy volunteers
Not accepted

Summary

Punctal stenosis is a progressive constriction of the puncta with resultant epiphora. One of the most effective treatment options is 1- to 4-snip punctoplasty combined with or without Mitomycin-C.

Conditions

Interventions

TypeNameDescription
PROCEDURE3-snip punctoplastypunctoplasty, more commonly known as watery eye surgery, is an ophthalmic surgical procedure performed to correct punctal stenosis (a condition that causes tears to overflow from the eyes) by widening the punctal opening to allow the tears to drain with ease.
PROCEDURE3-snip punctoplasty and Mitomycin Cpunctoplasty, more commonly known as watery eye surgery, is an ophthalmic surgical procedure performed to correct punctal stenosis (a condition that causes tears to overflow from the eyes) by widening the punctal opening to allow the tears to drain with ease. Mitomycin C is a chemotherapeutic agent that acts by inhibiting DNA synthesis

Timeline

Start date
2021-06-01
Primary completion
2022-06-01
Completion
2022-06-10
First posted
2022-10-19
Last updated
2022-10-19

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05586620. Inclusion in this directory is not an endorsement.